Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They F'd me once a while back and I almost got back in again to try and recoop some of my losses. Glad I didnt. Sorry for all that are stuck in this POS. I will just leave this one in the Sh!t pile and forget about it.
And they are using your money and mine to pay thier bills. Just not right. But guess thats the way it goes.
1 hour to go. Lets she whats she's got!!! ((NEWL))
All I can say is grab the bull by the nuts and hold on tight. It could get a little bumpy on the way up.....NEWL
Shorts are getting smelly. I smell crap....NEWL
12 to 15 equals 25% gain. Get in now before end of day run. NEWL
Back up she goes.....
Was a great buying opportunity....lets see what power hour brings.
As long as it keeps churning north we are in great shape here....15-16
Very nice buys coming in....
We need Beulla Ballbreaker!!!
I'm liking what I see here....count me in!!! NEWL
I know its old news but just wanted to post again. Sorry.
IsoRay Announces World's First Human Prostate Implant Utilizing Cesium-131 Seeds and C4 Imaging's Positive Signal MRI Markers
9:03a ET April 7, 2014 (Market Wire) Print
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the first prostate cancer implant combining IsoRay's Cesium-131 seeds with C4 Imaging's Sirius(R) positive signal MRI markers.
IsoRay CEO Dwight Babcock commented, "We are very excited to have our Cesium-131 isotope seeds chosen to partner with C4 Imaging's innovative positive signal MRI markers in the treatment of prostate cancer. By combining two of the newest technologies available in brachytherapy, we hope to demonstrate superior outcomes with the goal of improving patient lives. As we continue to develop our product offerings both internally and in partnership with other industry leaders, our message is clear and the medical community is becoming increasingly aware of the innovative alternative our Cesium-131 products offer to cancer patients."
Dr. Steven Frank of MD Anderson Cancer Center, who performed the implant, commented "IsoRay's Cesium-131, with its short half-life, offers rapid resolution of the acute side effects that can be associated with prostate treatment with brachytherapy".
Dr. Frank further stated "Strands utilizing IsoRay's Cesium-131 seeds and C4 Imaging's Sirius(R) MRI Markers bring together two novel technologies that permit MRI-based brachytherapy in order to optimize the treatment quality and outcomes of prostate cancer patients".
IsoRay's various products, including Cesium-131 seeds, sutured seeds, stranded mesh and the GliaSite(R) radiation therapy system, give physicians the ability to directly place a specified dosage of radiation in areas where cancer is most likely to remain after completion of a tumor removal or by placing seeds within the prostate. The ability to precisely place a specified dose of radiation means there is less likelihood for damage to occur to healthy surrounding tissue compared to other alternative treatments. IsoRay's cancer fighting products diminish the ability of the tumor to recur, resulting in important benefits for patients in longevity as well as quality of life.
Babcock said, "Leaders in the medical arena recognize the important need for a new powerful weapon in the battle against cancer and I believe Cesium-131 is that solution."
IsoRay is the exclusive manufacturer of Cesium-131. The pioneering brachytherapy therapy is one of the most significant advances in internal radiation therapy in 20 years. Cesium-131 allows for the precise treatment of many different cancers because of its unrivaled blend of high energy and its 9.7 day half-life (its unequaled speed in giving off therapeutic radiation).
In addition to its CMS codes, Cesium-131 is FDA-cleared and holds a CE mark for international sales in seed form for the treatment of brain cancer, prostate cancer, lung cancer, ocular melanoma cancer, colorectal cancer, gynecologic cancer, head and neck cancer and other cancers throughout the body. The treatment can be deployed using several delivery methods including single seed applicators, implantable strands and seed sutured mesh. IsoRay also sells several new implantable devices, including the GliaSite(R) radiation therapy system.
Seriously?
This is like being in a washing machine.....
Round 2 ding ding
That was quite a dip!!!!
Hell yea!!!!!
Anyone been watching ISR....its on fire!!!
Me too at 2.35
Smoking!!!!
It can only go up from here. JMO
Same here. But took some profits. Keeping close eye on this one.
Guess we will close 34 today down 5. Lets see what tomorrow brings. GLTA
NITE again!! WTF!!!!
They are swimming around. Just not enough plankton!!
F'n whackers!!! Could have closed 4 very easy....
NITE moved....lets get it!!!!
NITE stock blocking us again....wtf?
NITE blocking us at 42!! MOVE YOU POS!!!
42's going fast!!!!
Open them legs baby!!!! Leg it up!!!
Thank you guys for posting. Very nice!!!
Somebody post the news please. I dont see it.
Sounds like you have a cash account instead of a margin account. Just switch it. Also, you can only trade 3 day trades in 3 days or get restricted. Been there done that. Just check into it.
Another day of ups and downs only to end up where we began the day. Not so bad I say....Have a nice weekend everyone!!!
F'n Whackers!!!!
She said hit it dammit!!!!
No problem. Just watch out for snakes.....LOL